Table 1. Clinical Characteristics of... | American Society of Hematology

Table 1.

Clinical Characteristics of Poor-Risk AML Patients in This Study

Characteristic	No. of Patients
Age: median 54; range, 27 to 70 years old
Gender: male = 23, female = 14

De novo AML patients	27
Early relapse	11
Refractory AML	7
Second or greater relapse	5
Relapse post-BMT	4
Duration of 1st remission <6 months^*	20
Prior salvage therapy	15
Prior salvage responses	6
Unfavorable cytogenetics^†	11
Antecedent hematologic disease^‡	10
Unfavorable cytogenetics^†	7
Total no. of patients	37

Characteristic	No. of Patients
Age: median 54; range, 27 to 70 years old
Gender: male = 23, female = 14

De novo AML patients	27
Early relapse	11
Refractory AML	7
Second or greater relapse	5
Relapse post-BMT	4
Duration of 1st remission <6 months^*	20
Prior salvage therapy	15
Prior salvage responses	6
Unfavorable cytogenetics^†	11
Antecedent hematologic disease^‡	10
Unfavorable cytogenetics^†	7
Total no. of patients	37

Duration of first remission, including six patients with prior salvage efforts.

Abnormalities of chromosome 5 and/or 7, or complex (≥3 abnormalities).

Refers to AML developing after myelodysplastic syndrome or myeloproliferative disorders (excluding chronic myeloid leukemia).